Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis
Article in BMC Cancer (February 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Article in BMC Cancer (February 2024)
Article in Biomedicines (January 2024)
Article in Pneumologie (January 2024)